Вакцина Ваксарт против COVID-19

Вакцина Ваксарт против COVID-19
Описание вакцины
Цель	SARS-CoV-2
Тип вакцины	Вирусный вектор
Клинические данные
Другие имена	VXA-CoV2-1, VXA-CoV2-1.1-S
Маршруты администрация	Оральный

COVID-19 пандемия
Часть серии о
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
COVID-19 (болезнь) SARS-CoV-2 (вирус) Случаи Летальные исходы
Хронология 2019 2020 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November responses December responses 2021 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November responses December responses 2022 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November December 2023
Локации By country and territory Africa Antarctica Asia Europe North America Oceania South America By conveyance Cruise ships Naval ships
Международный ответ Endemic phase Evacuations Face masks International aid Origin Lockdowns by country Misinformation by governments Fake treatments Social distancing Software Travel United Nations World Health Organization WTO IP waiver Undercounting of deaths COVID-19 apps Zero-COVID National responses Africa China European Union Germany Ghana India Ireland Netherlands New Zealand Nigeria Philippines Russia Sweden UK government US federal government Vietnam
Медицинский ответ Disease testing Breathalyzer Development Drug development Drug repurposing Public health mitigation Vaccines History Research VITT Deployment Authorizations Operation Warp Speed Misinformation and hesitancy US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V
Варианты Variants of concern Alpha Beta Gamma Delta Omicron Other variants Epsilon Zeta Eta Theta Iota Kappa Lambda Mu Cluster 5 Lineage B.1.617
Экономические последствия и рецессия Arts and culture Aviation Cannabis Cinema films Disney Fashion Financial markets Food industry Food security Journalism Music Performing arts Retail Shipping Television US sportscasting programs Tourism Video games By country Canada India Ireland Malaysia New Zealand Russia UK US By sport Association football Baseball Basketball Combat sports Cricket Disc golf Gaelic games Gridiron football Ice hockey Motorsport Rugby league
Воздействие Animals Alzheimer's disease patients Black people Crime Death rates by country Disability Domestic violence Emergency evacuations Education Female Environment Hospitals Language LGBT community Long-term care Media coverage Mental health symptoms Migration Military Notable deaths Other health issues Politics diplomacy Popular culture Protests Pregnancy Prisons Religion Catholic Church Hajj Science and technology Social media Strikes Suicides Telehealth Xenophobia and racism Society Ireland Malaysia New Zealand Russia UK US
Портал COVID-19
v т и

Вакцина Vaxart против COVID-19 — это вакцина-кандидат против COVID-19, разработанная Vaxart . ^[1]^[2]^[3]

Ссылки [ править ]

^ Номер клинического исследования NCT04563702 «Испытание безопасности и иммуногенности пероральной вакцины против SARS-CoV-2 (VXA-CoV2-1) для профилактики COVID-19 у здоровых взрослых» на сайте ClinicalTrials.gov.
^ Номер клинического исследования NCT05067933 «Ph 1b: Безопасность и иммуногенность пероральной норовирусной вакцины на основе Ad5 (VXA-NVV-104)» на сайте ClinicalTrials.gov.
^ Номер клинического испытания NCT05067933 «Испытание Ph 2 с пероральной таблетированной вакциной против COVID-19» на сайте ClinicalTrials.gov.